-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ziv-aflibercept in Metastatic Uveal Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ziv-aflibercept in Metastatic Uveal Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ziv-aflibercept in Metastatic Uveal Melanoma Drug Details: Ziv-aflibercept (Zaltrap / Aflitiv...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ziv-aflibercept in Uveal Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ziv-aflibercept in Uveal Melanoma Drug Details: Ziv-aflibercept (Zaltrap / Aflitiv / Lidaveg / Zaltrapziv /...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ANX-005 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANX-005 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANX-005 in Amyotrophic Lateral Sclerosis Drug Details: ANX-005 is under development...
-
Sector Analysis
Electrical Substations in Utilities 2.0 – How Tech is Driving the Sector Innovation
Electrical Substations in Utilities 2.0 Report Overview The electrical substations in utilities 2.0 research report provides insights on the patent landscape, the latest news, partnerships, and company filings. The report will help to understand key disruptive forces in the power & utilities sector as it explores the emerging, accelerating, and maturing innovation areas with disruptive potential in power & utilities, along with the key players. Key Technologies ·      Digital Twins ·      AI and ML ·      Communication technologies ·      Smartification of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ziv-aflibercept
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ziv-aflibercept Drug Details Ziv-aflibercept (Zaltrap / Aflitiv / Lidaveg / Zaltrapziv / Zalzen) is...
-
Product Insights
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Placenta Growth Factor pipeline drugs market research report outlays comprehensive information on the Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also reviews key players involved in Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Vascular Endothelial Growth Factor B also known as VEGFB is a protein encoded by the VEGF-B gene. It regulates the formation of blood vessels and is involved in endothelial cell physiology. It is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). The Vascular Endothelial Growth Factor - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Vascular Endothelial Growth Factor, complete with analysis by stage of development, drug target,...
-
Sector Analysis
PharmaPoint: Colorectal Cancer – Global Drug Forecast and Market Analysis to 2025
The colorectal cancer (CRC) market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased number of diagnosed CRC incidence, and the launch and uptake of premium-priced therapies. Traditionally, the CRC market has been dominated by two therapeutic classes: angiogenesis and EGFR inhibitors. However, the efficacy of these agents is limited by the insurgence of acquired resistance. Further, RAS...